Article Versions Notes

Textor A, Grunewald L, Anders K, Klaus A, Schwiebert S, Winkler A, Stecklum M, Rolff J, Henssen AG, Höpken UE, et al. CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus. Cancers. 2021; 13(5):1050. https://doi.org/10.3390/cancers13051050

Textor, Ana, Laura Grunewald, Kathleen Anders, Anika Klaus, Silke Schwiebert, Annika Winkler, Maria Stecklum, Jana Rolff, Anton G. Henssen, Uta E. Höpken, and et al. 2021. "CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus" Cancers 13, no. 5: 1050. https://doi.org/10.3390/cancers13051050

Textor, A., Grunewald, L., Anders, K., Klaus, A., Schwiebert, S., Winkler, A., Stecklum, M., Rolff, J., Henssen, A. G., Höpken, U. E., Eggert, A., Schulte, J. H., Jensen, M. C., Blankenstein, T., & Künkele, A. (2021). CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus. Cancers, 13(5), 1050. https://doi.org/10.3390/cancers13051050